Inhibition of c-MYC, on the other hand, has been observed to promote apoptosis, growth arrest, differentiation, senescence, metabolic changes, as well as tumour regression in several human cancer models, clearly indicating its potential as a target for anti-cancer therapeutics6–9. Here, MYC is linked to cancer.